SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Nvidia is trending as investors monitor its tight consolidation phase, with the community debating whether the stock's relative performance against other semiconductor leaders signals a looming breakout or potential overvaluation. Market participants remain focused on the stock's critical role in global AI infrastructure and are actively analyzing volume and technical levels as they anticipate significant momentum following upcoming earnings.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is surging as investors cheer the semiconductor sector's broader AI momentum, heavily fueled by sympathy gains following a strong earnings report from Intel. While the community is actively debating whether this reflects sustainable demand or an overheating AI bubble, many are highlighting the rapid price expansion while navigating the volatility of a heavily shorted stock.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is seeing intense buying pressure and massive trading volume as the community rallies around its role in the optical connectivity sector and potential future integration with hyperscale data centers. Investors are actively debating the company's valuation and long-term potential, with bullish sentiment driven by management's recent commentary and ongoing institutional interest.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is seeing a massive surge in market interest and investor sentiment following a significant earnings beat and strong forward guidance that surprised many who were bearish on the stock. The community is actively debating whether this movement is driven by a genuine fundamental turnaround and structural AI demand, or if it represents an overextended short squeeze that is susceptible to a sharp retracement.

Atomera, Inc. engages in the development, commercialization, and licensing of proprietary processes and technologies for the semiconductor industry. It developed Mears Silicon Technology, which increases performance and power efficiency in semiconductor transistors. The company was founded by Robert Mears on November 26, 2001 and is headquartered in Los Gatos, CA.

Atomera Inc

Atomera is trending as investors digest the recent 25 million dollar direct offering and internal leadership shifts, including the strategic hire of a former Applied Materials executive to drive growth. Community discussion remains polarized, with some bulls highlighting potential breakthroughs in GAA and DRAM partnerships while critics continue to question the company's long-term commercial execution and revenue timeline.

Skillz, Inc. operates a mobile gaming platform that connects players in competition. It helps developers build franchises by enabling social competition in their games. Skillz hosts casual esports tournaments for mobile players worldwide. The company was founded by Andrew C Paradise and Casey Chafkin in 2012 and is headquartered in Las Vegas, NV.

Skillz Inc - Ordinary Shares - Class A

Skillz Inc

Skillz Inc is surging as investors react to a significant jury verdict awarding the company substantial damages in a lawsuit involving competitor Papaya Gaming. While the stock has seen extreme volatility and aggressive shorting, the community is intensely debating the potential for a major squeeze and whether the legal win provides long-term fundamental value.

MaxLinear, Inc. engages in the provision of communications systems-on-chip (SoC) solutions used in broadband, mobile and wireline infrastructure, data center, and industrial and multi-market applications. Its products include cable broadband modems and gateways, wireline connectivity devices, radio frequency transceivers, fiber-optic modules, video set-top boxes and gateways, hybrid analog and digital televisions, direct broadcast satellite outdoor and indoor units, and power management and interface products. The company was founded by Kimihiko Imura, Curtis C. Ling, and Kishore V. Seendripu on September 25, 2003 and is headquartered in Carlsbad, CA.

MaxLinear Inc

MaxLinear is currently trending after a massive single-session surge driven by a strategic pivot toward AI-integrated data center infrastructure and strong forward revenue guidance. The community is actively debating the stock's sustainability, with some traders highlighting the potential for a long-term structural re-rating while others express caution regarding the rapid price appreciation and potential for a pullback.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo is trending as investors rally around its strategic positioning in the nuclear energy sector, bolstered by high-profile partnerships and a focus on meeting the immense electricity demands of AI data centers. The community is actively debating the company's long-term regulatory milestones and potential for future criticality, while closely monitoring technical price action and recent institutional accumulation.

VanEck ETF Trust - VanEck Semiconductor ETF

VanEck Semiconductor ETF

The semiconductor sector remains a central point of market debate, with the SMH ETF showing significant volatility as traders weigh record-breaking momentum against concerns over AI-driven capex sustainability and geopolitical bottlenecks. Community members are actively split between capitalizing on the sector's parabolic rise and positioning for a potential correction, driven by intense speculation on whether recent gains represent structural growth or a speculative bubble.

Navitas Semiconductor Corp. engages in the development of ultra-efficient gallium nitride (GaN) semiconductors. Its GaN power ICs integrate GaN power with drive, control and protection to enable charging, power density, and energy savings for mobile, consumer, enterprise, eMobility and new energy markets. The company was founded by Daniel Kinzer, Nick Fichtenbaum, Gene Sheridan, and Jason Zhang on August 12, 2020 and is headquartered in Torrance, CA.

Navitas Semiconductor Corp

Navitas Semiconductor is experiencing extreme volatility and intense community debate as investors weigh the stock's massive rally, driven by AI data center and power infrastructure narratives, against concerns over its financials and potential short-term exhaustion. While bulls highlight the company's GaN technology as a critical long-term play for AI energy efficiency, a vocal contingent of bears is actively shorting the stock, citing stretched valuations and the high probability of an equity offering.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Cipla, Pfizer ink partnership for exclusive marketing of four brands in India

Pfizer India and Cipla Limited have announced a strategic partnership where Cipla will exclusively market and distribute four of Pfizer's key brands in India. This collaboration aims to leverage Cipla's extensive distribution network to enhance patient access to essential medicines like Corex Dx, Dolonex, Neksium, and Dalacin C across the country.

Vietnam's Visionary Leaders Redefine Success at the Asia Pacific Enterprise Awards 2025

HO CHI MINH CITY, Vietnam , Oct. 10, 2025 /PRNewswire/ -- Vietnam's most visionary leaders and trailblazing enterprises took center stage at the Asia Pacific Enterprise Awards (APEA) 2025 Vietnam, held on 9 October 2025 at the GEM Center, Ho Chi Minh City . Organized by leading regional NGO Enterprise Asia, the prestigious awards program honored businesses and business leaders who are reshaping industries, embracing innovation, and driving sustainable growth. Vietnam’s Visionary Leaders Redefine Success at the Asia Pacific Enterprise Awards 2025 With the theme 'Showcasing Future-Ready Enterprises', this year's APEA celebrated organizations and leaders who are future-proofing their businesses amidst sweeping technological disruption and shifting economic landscapes. A highly selective judging process evaluated 342 nominees across four award categories: Master Entrepreneur, Inspirational Brand, Fast Enterprise, and Corporate Excellence. Each recipient stood out for their resilience, innovation, and commitment to creating lasting impact.

Indian equity markets snapped their eight-day losing streak, with the Nifty index reclaiming 24,800, driven by a 700-point rally in Nifty Bank. This came after the Reserve Bank of India held steady on repo rates and revised inflation forecasts lower. The central bank also announced a slew of reforms for the banking space, including increased loan limits.On Wednesday, the Sensex closed 715 points higher at 80,983, while the&nbsp;<a href="https://stocktwits.com/symbol/NIFTY50.NSE">Nifty 50</a> ended up 225 points at 24,836. Broader markets mirrored the optimism, with the Nifty Midcap index rising 0.8% and the Smallcap index gaining 1.1%.However, the retail investor sentiment surrounding the Nifty 50 remained ‘bearish’ by market close on Stocktwits.<figure class="image"><img style="aspect-ratio:813/102;" src="https://news.stocktwits-cdn.com/Screenshot_2025_10_01_155746_png_5955436f5e.webp" alt="Screenshot 2025-10-01 155746.png" width="813" height="102"><figcaption>Nifty sentiment and message volume on Oct 1 as of 3:50 pm IST. | source: Stocktwits</figcaption></figure>Stock MovesSectorally, barring PSU banks, all indices ended in the green. Media (+4%), pharmaceuticals (+1.2%), and real estate (+1%) saw strong buying. A notable mover in the media space was Sun TV, which closed with 12% gains.Kotak Mahindra Bank, Axis Bank, ICICI Bank, and HDFC Bank were among the top Nifty gainers, driven by the RBI’s reforms push.&nbsp;<a href="https://stocktwits.com/symbol/TATAMOTORS.NSE">Tata Motors</a> ended over 5% higher after its <a href="https://stocktwits.com/news-articles/markets/equity/tata-motors-demerger-takes-effect-retail-investors-to-benefit-says-analyst/chCor1mR39A">demerger</a> came into effect; the record date has been set at October 14.<a href="https://stocktwits.com/symbol/PFIZER.NSE">Pfizer India</a> rose 3% after US President Donald Trump announced a deal with the American parent company to provide key prescription medications at steeply discounted prices through a new government-run online platform. The rest of the pharmaceutical space also saw a relief rally, with Sun Pharma and Lupin gaining 3%.&nbsp;Shriram Finance gained 5% after the company shot down reports that Japan’s Mitsubishi UFJ Financial Group (MUFG) was in talks to buy a 20% stake worth ₹23,200 crore.Stock Calls<a href="https://stocktwits.com/equitycharcha">Ashok Kumar Aggarwal of Equity Charcha</a> is bullish on TVS Supply Chain Solutions. It recently inaugurated a new facility in Iowa (USA) to support local manufacturing. On its technical charts, he noted that its Relative Strength Index (RSI) was ranging between 37 and 45 on its daily, weekly, and monthly time frame charts.&nbsp;He shared a short-to-medium term trade call on TVS Supply with an accumulation zone between ₹124-₹126 with a stop loss at ₹118 on a closing basis. The short-term target is set at ₹142, and a medium-term target price is ₹161.<stembedurl>https://stocktwits.com/equitycharcha/message/630578691</stembedurl><a href="https://stocktwits.com/Ca_mayankchandel">Mayank Singh Chandel</a> shared a swing trade call on&nbsp;<a href="https://stocktwits.com/symbol/HINDZINC.NSE">Hindustan Zinc</a>. He noted that the stock was consolidating near the gap resistance at ₹483.05, with rising volumes indicating strong upside interest. Chandel recommended a buy on a close above ₹483.05, with a stop loss at ₹463 and a target price of ₹535.<stembedurl>https://stocktwits.com/Ca_mayankchandel/message/630585738</stembedurl>Markets: What Next?<a href="https://stocktwits.com/WealthFino">Krishna Pathak&nbsp;</a>highlighted Nifty support near the 24,540–24,600 zone, with immediate resistance around the 24,800–24,900 levels. He added that the index was trading above the 9-day Exponential Moving Average (EMA), which indicates a short-term bullish momentum. If it breaks out above 24,800, it could open the path towards 24,900–25,100. But sustained weakness below 24,600 can extend declines towards 24,540.<stembedurl>https://stocktwits.com/WealthFino/message/630580092</stembedurl>Globally, European markets traded higher, while US stock futures indicate a weak start on Wall Street after a deadlock over healthcare and government spending led to the US government shutdown for a first time in nearly seven years.For updates and corrections, email newsroom[at]stocktwits[dot]com.&nbsp;

(Photo by Indranil Aditya/NurPhoto via Getty Images)

Banking Rally Lifts Indian Markets: RBI Policy Boosts Nifty To 24,800, Sensex Ends Near 81,000

Benchmarks staged a strong comeback on RBI’s supportive policy measures, though retail sentiment on Nifty 50 remained ‘bearish’ on Stocktwits.

Equity

Shares of Pfizer, the Indian arm of U.S.-based Pfizer Inc., rose more than 2% on Wednesday after President Donald Trump announced a deal with the drugmaker to provide key prescription medications at steeply discounted prices through a new government-run online platform, ‘TrumpRX.’Deal AnnouncementSpeaking at the White House, Trump said Pfizer agreed to supply several of its most widely used drugs at “heavily discounted prices of anywhere between 50% and even 100%,” allowing patients to pay cash directly on the new TrumpRX website.&nbsp;He added that all new Pfizer drugs introduced in the U.S. will be sold at “most favored patient costs,” ensuring prices are comparable to the lowest charged internationally.Pfizer CEO Albert Bourla said the company’s deal with the Trump administration satisfies all of the President’s requirements.&nbsp;He added that Pfizer has secured a three-year grace period from proposed tariffs on pharmaceutical imports, while also cutting prices on certain drugs. “The President is absolutely right—tariffs are the most powerful tool to motivate behavior, and they clearly motivated ours,” Bourla said.Trump also warned that companies refusing to lower prices could face additional tariffs of 5% to 8%, as his administration continues to pressure drugmakers to expand U.S.-based production before Oct. 1, 2025.Analyst ViewSEBI-registered analyst Sunil Kotak said that Pfizer’s daily chart shows a sideways trend, with the 50-day simple moving average (SMA) around ₹5,200 and a strong supply zone between ₹5,200–₹5,300.&nbsp;<stembedurl>https://stocktwits.com/Technofunda24/message/630578299</stembedurl>He noted that the stock would need to close above ₹5,300 for a fresh up-move, while the relative strength index (RSI) stands at 52, indicating consolidation for now.What Is The Retail Mood?On Stocktwits, retail sentiment for Pfizer was ‘bullish’ amid ‘high’ message volume.<a href="https://stocktwits.com/symbol/PFIZER.NSE">Pfizer’s stock</a> has declined 2.8% so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, Pfizer’s logo is on a smartphone with an economic stock exchange index graph in the background. (Photo Illustration by Budrul Chukrut/SOPA Images/LightRocket via Getty Images)

Pfizer India Rises On Trump’s Drug Discount Deal — SEBI Analyst Eyes Breakout Above ₹5,300

Pfizer shares rose after the U.S. drugmaker struck a deal with the Trump administration to sell key medicines at steep discounts through a new federal website.

Indian equity markets have opened on a positive note as investors await the rate decision from India’s central bank. The street is expecting the Reserve Bank of India (RBI) to maintain a status quo with a dovish tone, but some expect a 25 bps rate cut.At 09:40 a.m. IST, the&nbsp;<a href="https://stocktwits.com/symbol/NIFTY50.NSE">Nifty 50</a> traded 59 points higher at 24,670, while the Sensex was up 182 points at 80,450. Broader markets were mixed, with the Nifty Midcap index rising 0.2% and Smallcap index trading flat.The retail sentiment on Stocktwits for the Nifty remained ‘bearish’ at market open.&nbsp;<figure class="image"><img style="aspect-ratio:802/94;" src="https://news.stocktwits-cdn.com/Screenshot_2025_10_01_094251_png_63cb54d831.webp" alt="Screenshot 2025-10-01 094251.png" width="802" height="94"><figcaption>Nifty sentiment and message volume on Oct 1 as of 9:40 am IST. | source: Stocktwits</figcaption></figure>Stock WatchSectorally, barring IT and PSU banks, rest of the sectors traded in the green, led by media, pharmaceuticals, real estate and autos.&nbsp;Shriram Finance rose over 2% as news reports suggest that Japan's MUFG is looking to buy a 20% stake in the company.&nbsp;Tata Motors rose 1% as its long-awaited demerger into passenger and commercial vehicle units takes effect today. <a href="https://stocktwits.com/symbol/TATAINVEST.NSE">Tata Investment</a> continues its bull run, with 4% gains in opening trade. Tata Sons, the holding company of Tata Group, holds a 0.10% stake in Tata Investment and has missed a regulatory deadline to become publicly listed as per RBI norms for NBFCs.&nbsp;<a href="https://stocktwits.com/symbol/PFIZER.NSE">Pfizer India shares</a> surged 5% after its US parent company received a three-year reprieve from tariffs on pharmaceutical imports imposed by US President Donald Trump.Lupin gained 3% following a USFDA nod for Rivaroxaban oral suspension drug, used to treat venous thromboembolism (VTE).<a href="https://stocktwits.com/symbol/RATEGAIN.NSE">RateGain shares</a> fell 3% as the company is considering acquiring Sojern and its subsidiaries through its wholly-owned subsidiary for $250 million.Newgen Software rose 2% on securing multiple deals across the UK, US, Ghana, and Dubai, with total contract wins exceeding $9 million. RITES too gained over 2% following a pact with Etihad Rail.&nbsp;Atlantaa shares surged 20% after the company entered into an agreement with IRCON International for undertaking a contract worth ₹2,485 crore.Stock CallsAnalyst&nbsp;<a href="https://stocktwits.com/Wisebull_co_in">Vinayak Gautam</a> shared three stock recommendations for Wednesday with a 1-week timeframe:<a href="https://stocktwits.com/symbol/JSWSTEEL.NSE">JSW Steel</a>: Buy at ₹1,142, with a target price of ₹1,164, and stop loss at ₹1,130<a href="https://stocktwits.com/symbol/RITES.NSE">RITES</a>: Buy at ₹246.04, with a target price of ₹254, and stop loss at ₹243<a href="https://stocktwits.com/symbol/AGIIL.NSE">Agi Infra</a>: Buy at ₹1,260, with a target price of ₹1280, and stop loss at ₹1,250<stembedurl>https://stocktwits.com/Wisebull_co_in/message/630573311</stembedurl>Markets: The Road AheadFrom a technical standpoint, SEBI-registered analysts on Stocktwits shared the trade setup.&nbsp;Analyst&nbsp;<a href="https://stocktwits.com/kyalashish">Ashish Kyal</a> said the Nifty index is managing to show reduced momentum on the downside, but has yet to see a close above the prior high. For Wednesday, a break below 24,580 can take prices to 24,520-24,480 levels. A close above<a href="https://stocktwits.com/topic/Gann">&nbsp;</a>Gann levels of 24,728 on a 15-minute timeframe is required to resume a positive trend to 24,780-24,820. A move is expected 10 minutes after the RBI policy decision.<stembedurl>https://stocktwits.com/kyalashish/message/630572014</stembedurl><a href="https://stocktwits.com/prabhatmittal1">Prabhat Mittal</a> identified Nifty support at 24,450 with resistance at 24,850. For Bank Nifty, he sees support at 54,300 and resistance at 54,900.<stembedurl>https://stocktwits.com/prabhatmittal1/message/630571237</stembedurl>Global CuesGlobally, Asian markets traded mostly higher, while crude oil prices held steady.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.

Indian Markets Open Firm Ahead Of RBI Policy; Tata Investment, Pfizer, Shriram Finance Gain Ground

 Pharma, autos, and media stocks led early gains, while Tata Motors and Atlantaa were among top movers.

Indian stocks are poised for a subdued opening on Wednesday, as the GIFT Nifty — an early indicator for the Nifty 50 index — traded flat ahead of the market open. Benchmark indexes ended lower for the eighth straight session on Tuesday, with the Nifty index closing below 24,700.All eyes will also be on the Reserve Bank of India’s (RBI) rate decision due at 10 am today. Economists expect the central bank to hold steady on rates but a dovish tone could open the path for further rate cuts going forward. Rate sensitive sectors will be in focus today.&nbsp;Most major Asian markets were mostly higher in morning trade, barring Japanese Nikkei that was down nearly 1%. Chinese markets are shut for a week for National Day holidays.Stock WatchPfizer India: The US parent company has received a three-year reprieve from tariffs on pharmaceutical imports imposed by US President Donald Trump.Aurobindo, Dr Reddy’s, other Indian pharma companies: Trump's 100% tariff on pharma takes effect todayLupin - Got USFDA nod for Rivaroxaban oral suspension drug, used to treat venous thromboembolism (VTE).Auto stocks - Investors will be tracking September sales data.Shriram Finance - News reports suggest that Japan's MUFG is looking to buy 20% stake in the company.&nbsp;Nestle India - Has signed a Memorandum of Understanding (MoU) to boost investments in Odisha &amp; existing plants.Shree Cement - The company commissioned 3.65 MTPA clinkerisation unit in Rajasthan.Indian Overseas Bank - Got ₹31.8 lakh penalty notice from RBI for non-compliance of its Priority Sector Lending (PSL) targets and classification norms.OIL India &amp; GAIL - signed a pact to boost collaboration across the natural gas value chainRateGain - The company is considering acquiring Sojern and its subsidiaries through its wholly-owned subsidiary for $250 million.Newgen Software - Company has signed multiple deals across the UK, US, Ghana, and Dubai, with total contract wins exceeding $9 million.RITES - The company has signed a pact with Etihad Rail and its subsidiary to boost collaboration in the mobility sector across the UAE.&nbsp;Atlantaa - The company has entered into an agreement with IRCON International for undertaking a contract worth ₹2,485 crore.Swan Defence has signed a Memorandum of Understanding (MoU) with Samsung Heavy Industries to jointly explore commercial shipbuilding and heavy engineering projects across domestic and international markets.Mainboard Listing Today&nbsp;Epack Prefab Technologies, BMW Ventures, and Jain Resource RecyclingFor updates and corrections, email newsroom[at]stocktwits[dot]com.

The digital broadcast on the facade of the Bombay Stock Exchange (BSE) displays the benchmark share index SENSEX crossing 32,000 points, on July 13, 2017 in Mumbai, India. (Photo by Kunal Patil/Hindustan Times via Getty Images)

Sensex, Nifty Poised For Quiet Start; Pfizer, Lupin, Tata Motors, RateGain, Newgen, RITES On Stock Watchlist

 After eight days of losses, markets may see a cautious start as the RBI policy decision takes center stage. Stock-specific action is expected in pharma, auto, and PSU banking counters.

DPIIT partners with Pfizer to boost lab-to-market pathway for healthcare innovation

New Delhi, Sep 4 : The Department for Promotion of Industry and Internal Trade (DPIIT) has signed a Memorandum of Understanding (MoU) with US-based pharma giant Pfizer to strengthen Indias healthcare and accelerate the lab-to-market journey of healthcare innovations, the Ministry of Commerce and Industry said on Thursday. The collaboration will extend both financial and non-financial support to startups. Under the partnership, the Pfizer INDovation programme will empower DPIIT-recognised startups with grants of up to Rs 60 lakhs each, along with a tailored 18-month incubation programme delivered by Social Alpha. The programme will provide dedicated acceleration tracks covering clinical validation, regulatory approvals, and go-to-market strategies. Startups will also gain access to expert mentorship, infrastructure, and global networks, in addition to exposure at Pfizers Research and Development facilities in Chennai, enabling them to strengthen innovations with advanced industry insights, the Ministry said.

Pfizer Ltd. engages in the business of manufacturing, marketing, trading, import and export of pharmaceutical products. Its product offerings include treatment for depression, erectile dysfunction, high cholesterol, human immunodeficiency virus infection, hypertension, bacterial infections and systemic fungal infections, and other chronic therapeutic which includes pain, respiratory, vitamins or minerals, hospital anti-infectives, neurosciences, and cardiovascular. The firm's products include Prevenar 13, Ativan, Zosyn, Minipress XL, Meronem, Enbrel, Dolonex, Magnex, Trulimax, Neksium, Becosules, Gelusil, Mucaine, Folvite, Autrin, Citralka, and Corex Range. It operates through the India and Outside of India geographical segments. The company was founded on November 21, 1950 and is headquartered in Mumbai, India.

Current Price	4,712.00
Prev Close	4,780.50
Open	4,783.20
Dividend Yield	0.87%
50-Day Moving Average	4,866.47
Beta	0.05
Avg. Volume	20,426.47
PE Ratio	25.37

52-Week High	5,873.50
52-Week Low	4,009.00
Market Capitalization	218.77B
EPS (Annual)	167.79
Price to Book	5.63
Revenue Per Employee	12.9M

PFIZER.NSE
Pfizer Ltd.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest PFIZER.NSE News

PFIZER.NSEPfizer Ltd.